Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma

Liposomes constitute one of the most popular nanocarriers for improving the delivery and efficacy of agents in cancer patients. The purpose of this study was to design and evaluate immunoliposome co-delivery of bufalin and anti-CD40 to induce synergetic therapeutic efficacy while eliminating systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Yuan, Jiani, Yang, Qian, Cao, Wei, Zhou, Xuanxuan, Xie, Yanhua, Tu, Honghai, Zhang, Ya, Wang, Siwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260685/
https://www.ncbi.nlm.nih.gov/pubmed/25506218
http://dx.doi.org/10.2147/IJN.S73651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260685/
https://www.ncbi.nlm.nih.gov/pubmed/25506218
http://dx.doi.org/10.2147/IJN.S73651

Ejemplares similares